N

NLS Pharmaceutics Ltd
D

NLSP

3.24000
USD
-0.25
(-7.16%)
مغلق
حجم التداول
3,695
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
3,797,115
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BGNE
    -4.190
    (-2.51%)
    162.540 USD
    B
    BLUE
    -0.06000
    (-5.26%)
    1.08000 USD
    F
    FATE
    -0.46000
    (-8.61%)
    4.88000 USD
    G
    GH
    -1.770
    (-5.04%)
    33.380 USD
    I
    IOVA
    -0.58000
    (-6.64%)
    8.16000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    R
    RARE
    -0.870
    (-1.93%)
    44.140 USD
    VRTX
    9.75
    (1.97%)
    484.2 USD
    المزيد
الأخبار
المقالات

العنوان: Nls Pharmaceutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.